Your session is about to expire
← Back to Search
Palliative Care for Blood Cancer (PALS_CT Trial)
PALS_CT Trial Summary
This trial will compare early palliative care to standard care for patients and their family caregivers undergoing hematopoietic stem cell transplantation for blood cancers.
PALS_CT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPALS_CT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PALS_CT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Standard Care
- Group 2: Palliative and Supportive Care Intervention
Frequently Asked Questions
To what extent is the pool of participants being expanded for this clinical trial?
"Affirmative, clinicaltrials.gov shows that this medical trial is presently looking for individuals to take part in the study. This investigation was first posted on April 8th 2022 and its details were recently updated on the same day. Approximately 152 patients are needed for the research which will be conducted at a single site."
Are individuals able to join the program currently?
"Affirmative. The details listed on clinicaltrials.gov verify that this trial, which was first made public on April 8th 2022, is currently recruiting patients. 152 individuals are needed to be signed up from 1 medical centre."
Share this study with friends
Copy Link
Messenger